≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Injury of muscle and tendon at ankle and foot level

MESH Endpoint Browser

ST19_INJURY_MUSCLE_TENDON_ANKLE_FOOT_LEVEL

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — S96
  • Cause of death: ICD-10 — S96

2 out of 7 registries used, show all original rules.

924

4. Check minimum number of events

None

924

5. Include endpoints

None

924

6. Filter based on genotype QC (FinnGen only)

924

Control definitions (FinnGen only)

Control exclude
ST19_INJURI_ANKLE_FOOT

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
S90
Name in latin
Laesio musculi et/sive tendinis in regione tarsi/pedis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 924 468 456
Unadjusted period prevalence (%) 0.18 0.16 0.20
Median age at first event (years) 48.83 46.28 51.45

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
821
Matched controls
8211
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
NHL30
NOMESCO Finland
Suture or reinsertion of tendon of foot
613.3
323.0
351
10
S96.8
ICD-10 Finland
Injury of other muscles and tendons at ankle and foot level
4239.0
323.0
295
*
S96.1
ICD-10 Finland
Injury of muscle and tendon of long extensor muscle of toe at ankle and foot level
+∞
278.5
251
*
S96.9
ICD-10 Finland
Injury of unspecified muscle and tendon at ankle and foot level
514.4
135.3
131
*
S96.0
ICD-10 Finland
Injury of muscle and tendon of long flexor muscle of toe at ankle and foot level
+∞
111.0
104
*
X58
ICD-10 Finland
Exposure to other specified factors
6.6
90.6
270
567
X59
ICD-10 Finland
Exposure to unspecified factor
5.0
76.0
298
841
S93.4
ICD-10 Finland
Sprain and strain of ankle
7.8
54.9
135
203
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
6.7
49.5
135
234
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.4
49.3
307
1220
S91.3
ICD-10 Finland
Open wound of other parts of foot
17.2
44.3
71
45
S96.2
ICD-10 Finland
Injury of intrinsic muscle and tendon at ankle and foot level
+∞
44.2
42
*
S96.7
ICD-10 Finland
Injury of multiple muscles and tendons at ankle and foot level
+∞
34.6
33
*
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
6.4
33.9
93
160
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
15.2
31.9
53
37
WX320
NOMESCO Finland
Spinalanesthesy
2.9
31.1
230
975
NHL99
NOMESCO Finland
Other operation on muscle or tendon of ankle or foot
34.0
30.2
39
12
NHL50
NOMESCO Finland
Tenolysis or tenosynovectomy of foot
46.9
29.9
36
8
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
6.4
28.4
77
130
NHE15
NOMESCO Finland
Suture or reinsertion of ligament of ankle
42.9
27.0
33
8
L16
ICPC
Ankle symptom/complaint
3.8
26.5
123
368
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
13.2
25.6
45
36
S93.2
ICD-10 Finland
Rupture of ligaments at ankle and foot level
33.2
24.8
32
10
W22
ICD-10 Finland
Striking against or struck by other object(s)
4.2
24.4
98
257
N02AJ06
ATC
codeine and paracetamol; systemic
2.2
24.3
350
2065
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
5.1
24.0
79
169
B01AB05
ATC
enoxaparin; parenteral
2.3
22.7
260
1366
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.1
22.4
415
2697
N02BE01
ATC
paracetamol; systemic, rectal
2.3
19.8
693
5725
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
4.9
19.6
66
145
TQW40
NOMESCO Finland
Remowal of suture of skin
3.7
19.5
91
271
W31
ICD-10 Finland
Contact with other and unspecified machinery
7.1
19.1
47
70
W19
ICD-10 Finland
Unspecified fall
3.3
17.6
92
300
S91.1
ICD-10 Finland
Open wound of toe(s) without damage to nail
14.3
17.4
29
21
S92.3
ICD-10 Finland
Fracture of metatarsal bone
11.4
17.3
32
29
J01DB01
ATC
cefalexin; oral
2.2
17.3
681
5676
W26
ICD-10 Finland
Contact with other sharp object(s)
10.7
16.8
32
31
ZXA00
NOMESCO Finland
Right side
2.2
16.7
210
1128
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
9.3
16.5
34
38
ZXA05
NOMESCO Finland
Left side
2.2
16.5
205
1093
QDB00
NOMESCO Finland
Suture of skin of lower limb
21.5
16.0
23
11
N02AX02
ATC
tramadol; systemic, rectal
1.9
15.9
342
2257
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
4.9
15.5
51
110
M01AE01
ATC
ibuprofen; systemic, rectal
2.6
15.1
753
6668
W25
ICD-10 Finland
Contact with sharp glass
14.3
15.1
25
18
S18
ICPC
Laceration/cut
1.9
15.0
322
2110
W27
ICD-10 Finland
Contact with nonpowered hand tool
11.6
14.9
27
24
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.2
14.7
56
140
S96
ICD-10 Finland
Injury of muscle and tendon at ankle and foot level
152.6
14.5
15
*
TNG34
NOMESCO Finland
Major custom moulded orthopaedic cast, knee or lower leg
9.4
14.3
29
32
S99.9
ICD-10 Finland
Unspecified injury of ankle and foot
8.0
13.9
31
40
NHL68
NOMESCO Finland
Tenodesis, shortening or lengthening of tendon of foot
9.3
13.8
28
31
NH1AD
NOMESCO Finland
Ankle and foot CT
9.0
13.6
28
32
T93.5
ICD-10 Finland
Sequelae of injury of muscle and tendon of lower limb
26.2
13.4
18
7
TNH33
NOMESCO Finland
Custom moulded brace, ankle or foot
7.6
13.1
30
41
M79.6
ICD-10 Finland
Pain in limb
1.8
12.7
277
1802
NHJ50
NOMESCO Finland
Open reduction of fracture of foot or toe
131.9
12.5
13
*
M25.5
ICD-10 Finland
Pain in joint
1.9
12.1
230
1425
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
4.7
12.0
40
88
M01AH05
ATC
etoricoxib; oral
1.7
11.8
473
3662
N03AX12
ATC
gabapentin; oral
2.2
11.0
122
611
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.4
10.9
98
442
S86.0
ICD-10 Finland
Injury of Achilles tendon
4.7
10.8
36
80
M54.5
ICD-10 Finland
Low back pain
1.7
10.7
251
1653
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
2.6
10.7
78
317
M01AE03
ATC
ketoprofen; systemic, rectal
1.7
10.6
281
1916
S83.2
ICD-10 Finland
Tear of meniscus, current
2.7
10.6
76
304
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
2.8
10.5
69
262
M01AB05
ATC
diclofenac; systemic, rectal
1.6
10.4
524
4252
NHL10
NOMESCO Finland
Suture or reinsertion of achilles tendon
7.9
10.4
23
30
NHF25
NOMESCO Finland
Operation for debridement of ankle joint, arthroscopic
10.8
10.3
19
18
M02AA07
ATC
piroxicam; topical
1.7
10.2
256
1713
TNH31
NOMESCO Finland
Prefabricated orthosis, ankle or foot
10.2
10.0
19
19
L03
ICPC
Low back symptom/complaint
1.8
10.0
184
1116
S92.5
ICD-10 Finland
Fracture of other toe
5.5
9.9
28
52
M01AX17
ATC
nimesulide; oral
1.9
9.9
172
1023
S83.4
ICD-10 Finland
Sprain and strain involving (fibular)(tibial) collateral ligament of knee
4.1
9.8
37
93
SPAT1153
SPAT
Removal of sutures
1.7
9.8
226
1474
TNX34
NOMESCO Finland
Major custom molded cast, unspecified region
6.6
9.8
24
37
M01AC06
ATC
meloxicam; systemic, rectal
1.7
9.6
278
1936
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
9.5
124
664
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.4
9.5
77
333
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
4.2
9.4
35
87
M67.0
ICD-10 Finland
Short Achilles tendon (acquired)
10.8
9.3
17
16
NH1FA
NOMESCO Finland
Weight-bearing X-ray of ankle
9.7
9.3
18
19
TNX99
NOMESCO Finland
Other orthopaedic minor procedure
4.3
9.3
33
79
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
4.4
9.2
32
75
L17
ICPC
Foot/toe symptom/complaint
1.8
9.1
187
1173
NH3BG
NOMESCO Finland
MRI of foot
15.8
9.1
14
9
X50
ICD-10 Finland
Overexertion and strenuous or repetitive movements
4.4
9.0
31
72
W00
ICD-10 Finland
Fall on same level involving ice and snow
2.3
9.0
86
401
N03AX16
ATC
pregabalin; oral
1.8
8.8
175
1086
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
5.7
8.8
24
43
M19.0
ICD-10 Finland
Primary arthrosis of other joints
2.4
8.8
75
332
ZXD05
NOMESCO Finland
Urgent procedure
1.7
8.8
236
1601
TNH32
NOMESCO Finland
Custom moulded split, ankle or foot
10.2
8.5
16
16
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
8.5
269
1900
W45
ICD-10 Finland
Foreign body or object entering through skin
5.2
8.5
25
49
A02BC01
ATC
omeprazole; systemic
1.7
8.4
193
1253
S92.9
ICD-10 Finland
Fracture of foot, unspecified
+∞
8.3
8
*
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
2.0
8.2
102
534
M65.8
ICD-10 Finland
Other synovitis and tenosynovitis
4.5
8.1
27
61
M01AH01
ATC
celecoxib; oral (coxibs)
1.9
8.1
128
736
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
8.1
199
1316
NHE20
NOMESCO Finland
Plastic repair of capsule or ligament of ankle joint with transplant
22.3
8.0
11
5
M03BX02
ATC
tizanidine; oral
1.5
8.0
488
4020
Z3226
NOMESCO Finland
Physiotherapist
1.8
7.9
135
794
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
7.8
152
932
S91.0
ICD-10 Finland
Open wound of ankle
15.2
7.7
12
8
NH1EA
NOMESCO Finland
Ankle X-ray examination with load or wrench
15.2
7.7
12
8
NH1BG
SPAT
NA
7.5
7.7
17
23
M54.4
ICD-10 Finland
Lumbago with sciatica
1.9
7.7
126
729
A02BC03
ATC
lansoprazole; oral
1.6
7.7
201
1348
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
7.6
162
1024
Y28
ICD-10 Finland
Contact with sharp object, undetermined intent
10.1
7.5
14
14
NHA30
NOMESCO Finland
Exploration of joint of ankle or foot, arthroscopic
10.1
7.5
14
14
H02AB06
ATC
prednisolone; systemic
1.5
7.5
330
2514
M65.9
ICD-10 Finland
Synovitis and tenosynovitis, unspecified
3.8
7.4
30
82
NHL14
NOMESCO Finland
Shortening or lengthening of achilles tendon
13.5
7.4
12
9
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
2.0
7.3
96
511
J01DA01
ATC
[U] cefalexin; systemic
1.5
7.3
473
3905
S86.1
ICD-10 Finland
Injury of other muscle(s) and tendon(s) of posterior muscle group at lower leg level
15.9
7.2
11
7
M76.7
ICD-10 Finland
Peroneal tendinitis
8.0
7.1
15
19
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
7.1
128
764
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
4.6
7.1
23
51
SPAT1301
SPAT
No procedures
1.6
7.1
221
1544
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.0
7.1
87
455
S90.3
ICD-10 Finland
Contusion of other and unspecified parts of foot
5.0
7.0
21
43
WX400
NOMESCO Finland
Inhalation anesthesy
2.8
7.0
42
154
M25.2
ICD-10 Finland
Flail joint
5.9
6.9
18
31
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
6.9
397
3185
M77.4
ICD-10 Finland
Metatarsalgia
2.7
6.9
45
174
J01MA02
ATC
ciprofloxacin; systemic
1.5
6.8
269
1987
J01FF01
ATC
clindamycin; systemic
1.6
6.8
198
1360
A02BC02
ATC
pantoprazole; systemic
1.5
6.8
462
3830
Z71.8
ICD-10 Finland
Other specified counselling
1.6
6.8
177
1182
M76.6
ICD-10 Finland
Achilles tendinitis
3.0
6.8
37
128
M48.0
ICD-10 Finland
Spinal stenosis
2.1
6.8
76
383
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.9
6.7
106
609
N05CF02
ATC
zolpidem; oral
1.8
6.7
129
788
M24.2
ICD-10 Finland
Disorder of ligament
6.5
6.7
16
25
T93.2
ICD-10 Finland
Sequelae of other fractures of lower limb
6.5
6.7
16
25
L86
ICPC
Back syndrome with radiating pain
2.6
6.6
47
190
S93.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of foot
6.0
6.6
17
29
NHG26
NOMESCO Finland
Fusion between bones of ankle or ankle and foot
8.8
6.6
13
15
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.0
6.5
82
430
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.8
6.5
108
631
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.7
6.5
129
796
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
2.8
6.5
39
144
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.1
6.5
72
363
WX704
NOMESCO Finland
Intubation
2.3
6.5
58
266
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.5
6.4
445
3685
NHL20
NOMESCO Finland
Myotomy or tenotomy of foot
14.4
6.4
10
7
N06AX21
ATC
duloxetine; oral
2.0
6.3
83
446
WX702
NOMESCO Finland
Supraglottic ventilation device
2.6
6.3
44
175
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.6
6.3
166
1108
M66.4
ICD-10 Finland
Spontaneous rupture of other tendons
18.2
6.3
9
5
Z3231
NOMESCO Finland
Registered nurse
1.6
6.3
195
1359
S92.0
ICD-10 Finland
Fracture of calcaneus
+∞
6.3
6
*
S92.7
ICD-10 Finland
Multiple fractures of foot
+∞
6.3
6
*
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.2
6.1
60
286
R01AD09
ATC
mometasone; nasal
1.5
6.1
340
2689
M01AE02
ATC
naproxen; oral, rectal
1.4
6.1
420
3459
S93
ICD-10 Finland
Dislocation, sprain and strain of joints and ligaments at ankle and foot level
6.8
6.1
14
21

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013707) Erythrocyte sedimentation rate by Westergren method
652
5415
1.69
11.69
4.7
3.8
mm/h
9.9
10.5
0.61
610
5049
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
839
7630
2.08
9.66
15.0
12.3
mg/l
21.4
23.1
0.80
679
5914
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
191
1252
1.66
8.35
3.5
3.6
ng/l
817.2
560.2
0.20
132
918
(3042936) Bacteria identified in Isolate by Culture
158
985
1.73
8.32
1.9
2.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
432
3422
1.49
8.10
4.0
4.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
502
4125
1.48
7.68
4.6
4.9
mmol/l
6.7
6.6
0.10
475
3825
(3019550) Sodium [Moles/volume] in Serum or Plasma
836
7700
1.90
7.66
15.2
13.7
mmol/l
139.6
139.7
0.73
823
7503
(3023103) Potassium [Moles/volume] in Serum or Plasma
838
7728
1.91
7.60
15.3
13.8
mmol/l
4.0
4.0
0.10
825
7521
(3019069) Monocytes/100 leukocytes in Blood
435
3487
1.47
7.48
6.1
6.2
%
8.3
8.6
1.20
410
3279
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
645
5590
1.51
7.43
7.3
7.5
u/l
75.3
77.1
0.56
604
5273
(3013115) Eosinophils [#/volume] in Blood
471
3843
1.46
7.34
5.9
6.2
e9/l
0.2
0.2
0.56
431
3405
(3006315) Basophils [#/volume] in Blood
457
3709
1.46
7.31
5.7
5.9
e9/l
0.0
0.0
0.50
413
3233
(3022096) Basophils/100 leukocytes in Blood
420
3357
1.46
7.26
5.8
6.0
%
0.7
0.7
0.02
395
3149
(3006504) Eosinophils/100 leukocytes in Blood
431
3465
1.46
7.22
5.9
5.9
%
2.8
2.9
0.30
407
3239
(3002030) Lymphocytes/100 leukocytes in Blood
443
3592
1.45
7.02
5.9
6.0
%
29.4
28.5
1.02
416
3366
(3001604) Monocytes [#/volume] in Blood
453
3698
1.44
6.87
5.7
5.9
e9/l
0.6
0.6
0.10
409
3218
(3018010) Neutrophils/100 leukocytes in Blood
437
3544
1.44
6.87
5.7
5.7
%
55.6
56.7
1.32
410
3333
(3037467) Urinalysis macro (dipstick) panel - Urine
585
5021
1.45
6.69
4.5
3.9
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
462
3813
1.42
6.45
5.7
5.9
e9/l
1.9
2.0
0.37
423
3389
(3001122) Ferritin [Mass/volume] in Serum or Plasma
405
3277
1.42
6.26
2.8
2.7
ug/l
116.0
118.8
0.11
377
3058
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
234
1724
1.48
5.92
1.3
1.2
u/ml
3.3
1.7
0.38
59
494
(42870588) Differential panel, method unspecified - Blood
307
2385
1.43
5.87
5.3
5.9
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
264
1997
1.45
5.82
2.3
2.1
u/l
168.0
213.4
0.65
241
1881
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
209
1514
1.49
5.73
1.7
1.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
401
3278
1.39
5.67
5.8
6.9
mmol/l
1.2
1.2
1.00
343
2758
(3013650) Neutrophils [#/volume] in Blood by Automated count
502
4264
1.39
5.62
8.9
9.3
e9/l
4.1
4.0
0.29
455
3741
(3031040) Bacteria [#/volume] in Urine by Automated count
542
4674
1.39
5.47
4.6
3.8
e6/l
9.2
128.1
—
6
60
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
750
6858
1.50
5.38
4.7
4.4
mu/l
1.8
2.0
0.78
703
6333
(3007461) Platelets [#/volume] in Blood
902
8674
2.68
5.32
21.2
18.0
e9/l
252.2
251.4
0.14
891
8486
(3024731) MCV [Entitic volume]
902
8678
2.66
5.24
21.1
17.9
fl
90.7
90.7
0.26
896
8572
(3035941) MCH [Entitic mass]
902
8679
2.65
5.22
21.1
17.9
pg
30.4
30.3
0.53
896
8571
(3026361) Erythrocytes [#/volume] in Blood
902
8680
2.65
5.20
21.1
17.9
e12/l
4.6
4.6
0.69
889
8469
(3010813) Leukocytes [#/volume] in Blood
902
8682
2.64
5.16
21.2
18.0
e9/l
6.6
6.7
0.51
887
8468
(3000963) Hemoglobin [Mass/volume] in Blood
902
8683
2.63
5.14
21.3
18.0
g/l
137.5
137.9
0.38
895
8572
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
637
5687
1.39
4.93
3.9
3.8
pmol/l
14.3
14.6
1.99
599
5200
(3024561) Albumin [Mass/volume] in Serum or Plasma
350
2867
1.36
4.63
4.9
4.9
g/l
35.8
36.3
0.96
326
2684
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
327
2656
1.36
4.56
2.0
1.8
pmol/l
101.6
95.5
1.58
170
1411
(3000494) Fungus identified in Specimen by Culture
127
870
1.53
4.50
1.4
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
123
838
1.54
4.47
1.7
1.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
350
2880
1.35
4.46
2.1
2.2
nmol/l
78.7
74.9
1.58
319
2616
(3026493) Urate [Moles/volume] in Serum or Plasma
242
1884
1.39
4.37
2.5
2.6
umol/l
3637.2
5419.7
0.31
210
1661
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
429
3648
1.33
4.33
5.5
6.5
umol/l
11.3
11.1
0.14
412
3467
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
860
8189
1.72
4.33
10.5
9.6
u/l
28.9
28.0
0.22
837
7943
(3007930) Methemoglobin/Hemoglobin.total in Blood
48
257
1.92
4.20
5.7
7.6
%
0.9
0.9
0.07
43
237
(3048689) Calprotectin [Mass/mass] in Stool
136
961
1.49
4.16
2.9
2.4
ug/g
105.3
128.3
0.56
116
774
(3002385) Erythrocyte distribution width [Ratio]
711
6531
1.38
4.15
17.6
15.0
%
13.5
13.5
0.41
701
6397
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
277
2225
1.35
4.07
2.6
2.5
u/l
58.6
56.1
0.28
258
2075
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
130
917
1.49
4.01
1.4
1.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
355
2964
1.32
3.99
5.3
6.2
mmol/l
1.2
1.2
0.46
326
2687
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
74
463
1.65
3.85
2.1
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
134
960
1.46
3.82
1.2
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
321
2656
1.32
3.81
9.4
8.1
inr
1.2
1.2
0.16
92
808
(3025941) Bacteria identified in Stool by Culture
71
441
1.66
3.80
1.2
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
212
1650
1.37
3.78
1.5
1.7
mg/l
0.9
1.0
0.18
152
1237
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
211
1644
1.37
3.73
2.1
2.0
mg/l
2.6
2.9
1.03
179
1400
(3047181) Lactate [Moles/volume] in Blood
42
227
1.89
3.60
5.7
8.5
mmol/l
1.4
1.2
0.61
37
194
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
768
7195
1.40
3.58
12.3
11.1
ml/min/173m2
85.0
86.0
0.74
646
5895
(36660697) Celiac disease serology panel - Serum
86
571
1.56
3.52
1.2
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
40
215
1.90
3.50
1.3
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
140
1030
1.42
3.47
1.4
1.3
titre
706.3
498.4
0.47
35
204
(40761511) CBC panel - Blood by Automated count
846
8083
1.55
3.44
13.8
11.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
170
1296
1.38
3.43
1.4
1.3
iu/ml
20.2
32.0
1.25
51
407
(3023368) Bacteria identified in Blood by Culture
223
1775
1.34
3.41
4.6
4.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
776
7306
1.39
3.31
4.4
4.1
mmol/l
5.8
5.9
0.79
722
6737
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
162
1234
1.38
3.28
1.3
1.2
u/ml
7.4
11.0
0.38
63
506
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
45
257
1.79
3.27
5.8
7.7
%
1.6
1.6
0.10
40
237
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
598
5433
1.29
3.26
3.6
3.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
72
469
1.58
3.22
2.2
3.0
ng/l
125.7
149.5
0.23
64
422
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
593
5387
1.28
3.21
3.2
3.1
u/l
45.3
48.1
0.52
563
5097
(3018572) Chloride [Moles/volume] in Blood
31
160
1.97
3.07
6.7
10.4
mmol/l
104.5
105.6
0.45
26
143
(3039000) Anion gap in Blood
31
160
1.97
3.07
6.7
10.4
mmol/l
11.4
11.3
0.05
26
143
(3015377) Calcium [Moles/volume] in Serum or Plasma
270
2254
1.28
2.86
2.6
3.4
mmol/l
2.4
2.3
0.29
240
2015
(3022145) Colonoscopy Study observation
113
830
1.41
2.84
1.3
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
30
159
1.92
2.78
1.3
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
299
2535
1.27
2.78
3.3
3.4
u/l
35.1
32.1
0.37
287
2414
(3033658) Prothrombin time (PT) actual/Normal
220
1800
1.29
2.71
3.7
3.7
%
94.4
92.3
0.62
212
1755
(3003338) MCHC [Mass/volume]
716
6719
1.29
2.69
19.1
15.5
g/l
333.9
333.4
0.77
711
6670
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
302
2574
1.26
2.67
3.3
3.2
ng/l
244.1
39.7
0.45
187
1647
(3044889) 12 lead EKG panel
563
5142
1.24
2.64
3.7
3.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
23
113
2.06
2.63
1.5
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
36
207
1.77
2.61
1.1
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
208
1698
1.29
2.61
1.9
2.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
133
1020
1.36
2.59
1.7
1.8
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
68
462
1.51
2.57
1.7
1.7
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
30
165
1.85
2.51
1.5
1.7
e6/l
9209.3
12720.0
0.34
21
128
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
26
138
1.91
2.43
1.7
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
190
1549
1.29
2.40
1.6
1.4
g/l
2.3
2.4
0.26
118
1002
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
60
407
1.51
2.30
1.1
1.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
53
353
1.53
2.22
7.7
13.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
21
107
1.99
2.21
1.3
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
262
2241
1.24
2.18
2.1
2.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
89
663
1.38
2.10
2.9
2.4
u/l
33.1
35.7
0.26
75
570
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
93
698
1.37
2.10
1.6
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
212
1780
1.25
2.09
6.5
6.7
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
242
2062
1.24
2.08
3.0
3.0
e6/l
23.9
83.5
1.14
180
1576
(3009508) Creatinine [Moles/volume] in Urine
254
2177
1.23
2.07
3.4
3.2
mmol/l
7.9
8.1
0.33
215
1854
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
728
6913
1.25
2.06
5.7
5.1
mmol/mol
39.7
39.2
0.56
690
6472
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
143
1147
1.29
2.05
2.1
3.0
mmol/l
2.4
2.4
0.77
122
1028
(3018095) Leukocytes [#/volume] in Urine
282
2456
1.21
1.95
3.4
3.4
e6/l
54.8
86.0
0.46
193
1709
(3026008) Bacteria identified in Urine by Culture
213
1805
1.23
1.92
3.1
2.6
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
33
204
1.64
1.91
1.2
1.2
u/ml
36.3
30.4
—
5
6
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
95
727
1.34
1.91
6.7
9.5
kpa
4.9
5.1
1.61
85
693
(3027801) Oxygen [Partial pressure] in Arterial blood
95
727
1.34
1.91
6.6
9.4
kpa
12.3
12.4
0.08
86
695
(3008152) Bicarbonate [Moles/volume] in Arterial blood
58
408
1.45
1.90
6.9
8.5
mmol/l
24.5
24.5
0.08
49
380
(4010399)
68
493
1.41
1.90
1.3
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
37
237
1.58
1.87
1.5
1.7
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
27
159
1.72
1.87
1.0
1.1
u/ml
3.4
6.4
0.74
19
79
(3009542) Hematocrit [Volume Fraction] of Blood
760
7276
1.25
1.85
15.9
13.0
%
40.7
40.6
0.02
591
5592
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
22
122
1.82
1.85
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
22
122
1.82
1.85
1.3
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
26
152
1.73
1.85
1.0
1.1
u/ml
0.9
1.7
0.35
14
60
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
29
175
1.68
1.84
1.1
1.1
u/ml
1.7
2.2
0.11
16
73
(3002619) Bacteria identified in Specimen by Culture
5
12
4.18
1.82
1.2
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
230
1976
1.22
1.81
1.7
1.7
mmol/l
1.4
1.4
0.53
196
1671
(46235355) HIV 1 and 2 tests - Meaningful Use set
196
1659
1.23
1.78
1.9
1.9
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
166
1380
1.25
1.78
1.6
1.6
pmol/l
328169439.3
54414684.3
0.71
142
1178
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
38
249
1.55
1.76
1.5
1.6
iu/ml
3.1
0.0
—
10
41
(3052592) Norovirus Ag [Presence] in Stool
5
13
3.86
1.71
1.2
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
81
616
1.35
1.71
3.4
4.4
%
0.5
0.9
0.60
21
177
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
91
705
1.32
1.70
1.6
1.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
137
1121
1.26
1.69
2.0
1.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
226
1952
1.21
1.68
4.1
4.0
ph
7.4
7.4
1.51
36
368
(3002173) Hemoglobin [Mass/volume] in Arterial blood
80
610
1.34
1.67
6.6
10.6
g/l
124.0
123.0
0.16
71
588
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
8
31
2.59
1.66
1.4
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
38
255
1.51
1.60
1.4
2.2
g/l
1.3
1.5
0.40
29
216
(3025159) Blasts/100 leukocytes in Blood
73
553
1.35
1.60
3.3
4.6
%
0.1
0.1
0.45
19
138
(3044242) Glucose [Moles/volume] in Arterial blood
8
32
2.51
1.60
1.4
3.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
29
183
1.60
1.59
1.2
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
76
580
1.34
1.59
1.9
1.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
92
724
1.30
1.55
6.7
9.5
mmol/l
1.0
1.2
0.14
63
573
(3016502) Oxygen saturation in Arterial blood
83
645
1.32
1.54
6.7
10.2
%
96.4
95.8
0.61
75
619
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
123
1007
1.26
1.52
2.0
1.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
58
428
1.38
1.50
5.0
6.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
30
194
1.56
1.50
2.2
1.7
—
—
—
0
0
(4035726)
42
588
0.70
1.46
1.5
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
102
822
1.27
1.45
2.3
2.8
umol/l
9.4
7.5
0.32
88
714
(3022217) INR in Platelet poor plasma by Coagulation assay
93
742
1.28
1.43
21.8
19.1
inr
1.2
1.2
0.24
24
109
(3012516) Albumin [Mass/volume] in Urine
223
1952
1.19
1.43
3.4
3.3
mg/l
46.6
245.9
1.93
144
1268
(3000492) Spirometry study
100
806
1.27
1.42
1.4
1.4
—
—
—
0
0
(3013512) EKG study
219
1916
1.19
1.41
3.7
3.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
210
1833
1.19
1.39
2.7
2.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
234
2062
1.18
1.39
3.9
4.0
mg/mmol
9.8
8.7
0.13
144
1331
(3021440) Promyelocytes/100 leukocytes in Blood
75
585
1.31
1.37
3.5
4.5
%
0.1
0.1
0.05
20
162
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
41
2.21
1.37
1.7
2.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
29
192
1.53
1.33
1.2
1.2
u/ml
2.3
10.8
—
6
29
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
285
2560
1.16
1.33
5.0
4.5
ug/l
2.4
2.3
0.07
264
2309
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
54
2.05
1.33
3.0
3.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
43
309
1.41
1.32
2.3
2.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
61
466
1.33
1.30
1.2
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
13
69
1.90
1.29
20.6
6.6
mmol/l
6.3
7.0
—
8
59
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
44
2.06
1.27
1.2
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
44
2.06
1.27
1.2
1.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
37
261
1.44
1.27
1.7
1.8
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
108
893
1.24
1.25
2.4
2.4
%
24.6
23.5
0.27
79
763
(40768443) Skin Pathology biopsy report
39
279
1.42
1.24
1.3
1.2
—
—
—
0
0
(4024509)
10
49
2.05
1.22
1.7
1.3
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
19
2.64
1.21
1.2
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
19
2.64
1.21
1.2
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
19
2.64
1.21
1.2
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
19
2.64
1.21
1.2
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
233
2075
1.16
1.21
4.6
3.9
%
21.0
21.2
0.09
104
918
(3019309) Folate [Moles/volume] in Red Blood Cells
129
1092
1.21
1.20
1.8
1.7
nmol/l
1081.9
1165.0
0.44
104
837
(3026389) Candida sp identified in Specimen by Organism specific culture
15
86
1.76
1.19
1.7
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
44
325
1.37
1.18
1.3
1.6
mu/l
220.7
269.6
1.23
39
294
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
23
149
1.56
1.18
3.6
3.7
%
60.0
55.5
1.08
23
149
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
32
223
1.45
1.18
2.9
2.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
785
7626
1.20
1.16
4.4
4.1
mmol/l
4.7
4.7
0.46
744
7161
(3019225) pH of Specimen
77
619
1.27
1.15
2.9
4.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
781
7586
1.19
1.14
4.4
4.1
mmol/l
1.5
1.4
0.74
737
7091
(3017732) Neutrophils [#/volume] in Blood
64
504
1.29
1.13
2.0
2.4
e9/l
4.0
4.1
0.11
46
411
(3019150) Specific gravity of Urine by Refractometry
181
1592
1.17
1.10
4.4
3.4
kg/l
1.0
1.0
0.97
33
210
(3009445) Proteinase 3 Ab [Units/volume] in Serum
39
286
1.38
1.10
1.7
1.6
—
10.3
—
0
13
(3008898) HLA-B27 [Presence]
43
321
1.36
1.09
1.1
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
41
1.96
1.09
1.4
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
41
305
1.36
1.07
2.6
1.9
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
58
455
1.29
1.06
3.0
3.9
ng/l
70.5
80.7
0.72
52
407
(3022948) Iron [Moles/volume] in Serum or Plasma
123
1051
1.20
1.05
2.3
2.3
umol/l
14.4
14.0
0.27
114
966
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
755
7326
1.17
1.05
3.9
3.7
mmol/l
1.3
1.3
0.02
710
6828
(3030467) Casts [#/volume] in Urine by Automated count
207
1848
1.15
1.04
2.8
2.9
e6/l
0.2
0.4
3.40
141
1378
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
793
7727
1.19
1.03
4.9
4.5
mmol/l
2.8
2.8
0.10
745
7206
(3036071) Salmonella sp Ab [Titer] in Serum
7
34
2.07
1.03
1.0
1.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
316
2907
1.13
1.02
2.0
2.0
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
7
35
2.01
1.00
1.0
1.1
—
10.9
—
0
10
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
35
2.01
1.00
1.0
1.1
miu/ml
960.7
1585.4
—
7
35
(3021601) Nitrite [Presence] in Urine by Test strip
388
3619
1.12
1.00
4.8
4.4
estimate
0.0
0.0
0.50
71
714
(3035350) Ketones [Presence] in Urine by Test strip
388
3620
1.12
0.99
3.6
3.2
estimate
0.0
0.0
0.00
70
692
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
13
76
1.72
0.99
1.8
1.6
%
79.9
59.7
—
8
52
(3021589) Normoblasts [#/volume] in Blood
355
3296
1.13
0.98
8.0
9.2
e9/l
0.0
0.0
0.11
300
2706
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
23
2.18
0.98
1.4
1.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
15
92
1.64
0.97
1.3
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
203
1820
1.15
0.97
4.5
4.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
26
182
1.44
0.97
1.3
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
9
50
1.81
0.96
1.6
1.6
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
0
32
0.00
0.95
0.0
1.8
—
43.1
—
0
5
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
14
85
1.66
0.94
1.1
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
43
330
1.32
0.94
1.6
2.2
u/l
15101.5
4744.2
—
8
141
(3024980) IgG subclass 4 [Mass/volume] in Serum
18
117
1.55
0.94
1.3
1.6
g/l
0.6
0.8
0.57
13
85
(3000850) Epithelial cells [#/volume] in Urine
160
1413
1.16
0.94
2.9
2.4
e6/l
5.0
5.7
0.31
139
1238
(3000093) Morphology [Interpretation] in Blood Narrative
9
52
1.74
0.92
1.0
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
81
675
1.22
0.92
3.4
2.5
%
1.7
1.8
0.20
71
604
(3010726) Horse dander IgE Ab [Units/volume] in Serum
22
151
1.47
0.91
1.0
1.1
u/ml
0.2
3.3
—
5
39
(3024522) Salmonella sp identified in Specimen by Organism specific culture
15
94
1.61
0.91
1.3
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
15
94
1.61
0.91
1.3
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
35
262
1.35
0.91
1.6
1.7
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
112
966
1.18
0.88
2.4
2.3
g/l
2.3
2.4
0.88
104
898
(3045788) Cell count panel - Pleural fluid
8
42
1.91
0.88
2.0
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
6
30
2.01
0.87
1.2
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
390
3662
1.11
0.87
3.6
3.2
estimate
0.0
0.0
0.80
68
673
(3021960) Folate [Moles/volume] in Serum or Plasma
167
1490
1.15
0.86
1.6
1.4
nmol/l
20.2
20.3
0.02
151
1266
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
108
933
1.18
0.84
2.0
1.7
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
28
205
1.38
0.84
1.4
1.4
ug/g
277.3
305.5
0.33
18
124
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
43
337
1.29
0.83
2.0
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
176
1582
1.14
0.82
3.6
3.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
47
1.71
0.80
1.3
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
47
1.71
0.80
1.1
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
47
375
1.27
0.80
3.1
2.5
e6/l
0.2
0.2
0.06
47
365
(3002179) Metamyelocytes/100 leukocytes in Blood
68
566
1.22
0.80
3.4
4.2
%
0.5
0.4
0.23
15
130
(40765089) Chromosome analysis panel - Blood by G-banded
6
33
1.82
0.79
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
0
27
0.00
0.77
0.0
1.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
27
0.00
0.77
0.0
1.0
—
4.1
—
0
7
(3017569) Oxygen content in Arterial blood
6
34
1.77
0.76
1.3
3.5
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
28
0.00
0.76
0.0
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
33
253
1.32
0.76
4.1
2.9
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
69
579
1.21
0.76
2.7
2.4
g/l
10.3
10.6
0.26
61
535
(3022621) pH of Urine by Test strip
52
424
1.24
0.75
3.5
2.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
19
266
0.71
0.74
1.5
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
54
1.67
0.74
2.0
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
24
2.09
0.74
1.2
1.0
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
188
1709
1.13
0.74
2.9
3.0
ng/l
987.4
993.5
0.01
151
1427
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
152
1364
1.14
0.73
1.7
1.6
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
25
2.01
0.72
1.0
1.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
14
92
1.53
0.72
1.2
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
14
92
1.53
0.72
1.2
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
40
1.76
0.71
1.6
1.9
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
57
1.58
0.71
1.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
16
109
1.48
0.71
1.3
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
228
2103
1.11
0.70
3.2
2.8
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
41
1.71
0.70
1.4
1.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
14
93
1.51
0.69
1.2
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
48
392
1.24
0.69
2.6
2.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
22
161
1.38
0.68
1.4
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
62
521
1.20
0.68
2.0
2.3
ug/l
11.7
7.7
0.35
57
469
(3014576) Chloride [Moles/volume] in Serum or Plasma
90
782
1.17
0.68
6.0
8.0
mmol/l
105.0
104.2
1.08
84
764
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
27
1.86
0.68
1.0
1.2
ug/l
9.2
8.7
—
5
27
(3023419) Bacteria identified in Sputum by Culture
14
94
1.50
0.67
1.8
2.4
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
7
43
1.63
0.67
1.7
1.3
—
23.9
—
0
7
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
167
1518
1.12
0.66
2.8
2.8
ug/l
0.9
0.7
0.36
107
936
(3012095) Magnesium [Moles/volume] in Serum or Plasma
124
1107
1.14
0.66
2.8
3.7
mmol/l
0.8
0.8
0.22
111
1048
(3027008) Opiates [Presence] in Urine
48
395
1.23
0.65
2.6
2.0
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
11
70
1.58
0.65
5.3
4.7
u/ml
138.0
41.3
—
6
26
(3023520) Reticulocytes [#/volume] in Blood
59
497
1.20
0.64
1.9
2.7
e9/l
68.8
70.9
0.17
44
371
(3028300) Cannabinoids [Presence] in Urine
48
396
1.22
0.64
2.6
2.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
127
0.63
0.64
1.1
1.9
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
80
694
1.17
0.63
2.7
2.3
nmol/l
12.6
13.1
0.29
74
627
(3028707) Methadone [Presence] in Urine by Screen method
22
164
1.35
0.62
3.6
2.6
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
37
299
1.25
0.60
2.4
1.8
nmol/l
36.6
36.9
0.04
37
288
(3000991) Gas panel - Venous blood
43
519
0.82
0.60
10.9
10.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
44
363
1.22
0.60
2.7
2.0
—
—
—
0
0
(4027681)
8
52
1.54
0.59
1.3
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
118
1060
1.13
0.58
2.3
2.8
e6/l
3.6
2.1
0.59
59
578
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
23
0.00
0.58
0.0
2.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
47
392
1.21
0.58
1.7
1.8
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
36
1.67
0.56
1.2
1.3
—
—
—
0
0
(4268621)
5
87
0.57
0.56
2.0
2.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
20
150
1.34
0.56
1.1
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
79
693
1.15
0.55
2.6
3.0
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
6
37
1.63
0.55
1.5
1.3
—
47.1
—
0
7
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
6
37
1.63
0.55
1.0
1.1
%
81.0
99.7
—
6
30
(4094501)
25
195
1.29
0.54
1.2
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
12
82
1.47
0.54
1.1
1.3
nmol/l
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
126
0.63
0.54
1.1
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
20
151
1.33
0.54
1.3
1.5
—
—
—
0
0
(3017704) Immunofixation for Urine
6
39
1.54
0.53
1.0
1.6
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
16
117
1.37
0.52
2.6
5.8
umol/l
287.8
386.3
1.87
11
103
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
30
242
1.25
0.51
1.4
1.5
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
41
1.47
0.50
8.7
7.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
11
156
0.70
0.50
4.0
3.9
—
—
—
0
0
(3020891) Body temperature
19
246
0.77
0.49
3.3
4.9
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
111
1006
1.12
0.49
1.6
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
303
2879
1.08
0.49
3.8
3.2
—
—
—
0
0
(3026782) Osmolality of Urine
143
1315
1.10
0.49
2.8
2.6
mosm/kgh2o
564.4
572.5
0.15
124
1110
(40768793) Breast Pathology biopsy report
11
154
0.71
0.47
1.2
1.3
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
26
209
1.25
0.47
1.7
2.3
mg/l
10.6
11.4
0.27
21
192
(40761535) Cells panel - Urine sediment
47
546
0.85
0.46
4.1
3.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
83
0.60
0.46
1.0
1.8
—
—
—
0
0
(21494434) Karyotype in Bone marrow
7
50
1.40
0.45
1.6
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
15
112
1.34
0.45
1.1
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
12
86
1.40
0.44
1.0
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
24
296
0.81
0.44
4.1
3.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
51
1.38
0.44
1.1
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
33
275
1.21
0.44
1.6
1.7
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
18
139
1.30
0.44
3.9
3.3
mg/l
37.2
26.4
0.41
12
91
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
123
1130
1.10
0.44
1.8
1.8
%
1.6
1.4
1.69
104
1014
(3042111) Morphology [Interpretation] in Bone marrow Narrative
14
104
1.35
0.43
2.6
1.7
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
8
56
1.43
0.42
1.6
1.4
mmol/l
5.6
6.8
—
8
51
(44790048)
12
87
1.38
0.42
1.6
1.7
—
—
—
0
0
(44806118)
12
87
1.38
0.42
1.6
1.7
—
—
—
0
0
(44790049)
12
87
1.38
0.42
1.6
1.7
—
—
—
0
0
(44790047)
12
87
1.38
0.42
1.6
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
295
3086
0.94
0.41
2.7
2.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
13
96
1.36
0.41
1.8
1.8
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
8
58
1.38
0.41
1.3
2.5
—
1.8
—
0
5
(3028026) IgM [Mass/volume] in Serum or Plasma
53
464
1.15
0.41
1.9
1.7
g/l
1.1
1.4
0.81
48
431
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
26
213
1.23
0.41
2.2
2.8
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
17
0.00
0.40
0.0
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
8
60
1.34
0.40
1.4
2.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
18
0.00
0.40
0.0
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
34
288
1.19
0.39
1.4
1.4
miu/ml
184.2
230.5
0.41
18
136
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
35
1.43
0.39
1.2
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
17
133
1.28
0.38
2.5
3.9
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
11
80
1.38
0.38
1.5
2.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
66
1.37
0.38
1.2
1.2
—
—
—
0
0
(4062490)
9
66
1.37
0.38
1.3
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
66
1.37
0.38
1.2
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
36
1.39
0.38
3.8
3.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
15
192
0.78
0.38
1.2
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
21
170
1.24
0.37
1.4
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
69
1.31
0.37
2.4
3.8
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
17
134
1.27
0.37
1.7
2.5
g/l
129.1
131.7
0.16
12
101
(3002523) Influenza virus A Ag [Presence] in Specimen
13
168
0.77
0.36
1.0
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
78
0.64
0.35
1.8
2.6
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
5
80
0.62
0.35
1.8
2.6
mmol/l
108.2
105.0
—
5
80
(3041354) Potassium [Moles/volume] in Venous blood
5
80
0.62
0.35
1.8
2.6
mmol/l
3.9
4.0
—
5
80
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
15
117
1.29
0.35
1.3
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
43
1.40
0.35
1.5
1.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
13
167
0.78
0.34
1.0
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
232
0.82
0.34
4.1
2.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
72
655
1.11
0.33
2.8
4.4
ug/l
13.8
28.4
0.45
58
535
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
10
74
1.36
0.32
1.3
1.7
nmol/l
16.5
20.2
—
10
69
(3019420) Tryptase [Mass/volume] in Serum or Plasma
6
47
1.28
0.32
1.2
1.3
ug/l
7.2
6.1
—
6
39
(3037756) Immunofixation for Serum or Plasma
16
128
1.25
0.32
2.9
1.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
15
119
1.26
0.32
2.5
2.8
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
23
193
1.20
0.31
4.6
3.6
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
53
1.32
0.31
1.9
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
48
429
1.13
0.30
1.2
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
55
1.27
0.30
1.0
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
35
398
0.87
0.29
1.3
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
12
152
0.79
0.29
1.3
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
216
2255
0.95
0.29
1.4
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
106
0.75
0.29
1.3
1.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
17
139
1.23
0.29
1.1
1.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
7
57
1.23
0.29
1.6
1.5
—
73.8
—
0
6
(3037121) Protein [Mass/volume] in Urine
21
248
0.84
0.28
1.9
3.7
g/l
0.3
0.2
—
6
103
(3023420) DNA double strand Ab [Units/volume] in Serum
10
76
1.32
0.28
1.8
1.5
—
34.2
—
0
5
(3044927) Protein electrophoresis panel - Urine
8
62
1.29
0.28
1.8
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
16
131
1.23
0.27
1.5
1.5
nmol/l
0.2
0.3
0.70
16
107
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
104
1.25
0.26
1.0
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
89
830
1.08
0.26
5.6
6.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
75
0.66
0.26
1.0
1.9
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
9
73
1.24
0.25
1.1
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
74
1.22
0.25
1.2
1.6
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
60
551
1.10
0.25
4.7
3.8
kpa
6.1
5.8
1.62
60
534
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
76
1.19
0.24
1.2
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
118
1116
1.07
0.24
2.3
2.6
e6/l
0.9
1.1
0.25
58
632
(3045142) Bone marrow Pathology biopsy report
6
82
0.73
0.24
1.2
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
57
524
1.09
0.23
2.8
3.8
mmol/l
1.2
1.2
0.28
49
448
(1002224) Polysomnography panel
44
399
1.11
0.23
1.1
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
50
546
0.91
0.23
1.2
1.2
iu/ml
28.1
173.7
11.73
17
220
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
38
1.32
0.23
1.4
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
114
1203
0.94
0.23
1.6
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
26
228
1.14
0.23
2.0
1.7
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
5
39
1.28
0.23
5.2
2.5
ug/l
34.8
229.4
—
5
33
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
11
88
1.25
0.22
1.0
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
25
219
1.15
0.22
1.1
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
14
116
1.21
0.22
1.4
1.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
41
1.22
0.22
1.8
1.3
nmol/l
105.8
145.6
—
5
41
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
41
1.22
0.22
1.2
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
17
144
1.18
0.22
1.5
1.8
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
10
0.00
0.21
0.0
1.0
—
10.8
—
0
5
(3014148) Varicella zoster virus Ab [Titer] in Serum
12
98
1.23
0.21
1.0
1.2
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
0.5
—
0
6
(44806071)
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.5
—
0
7
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
12
0.00
0.21
0.0
3.6
—
6295.3
—
0
12
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
104
0.77
0.21
1.0
1.7
—
—
—
0
0
(3012501) Base excess in Blood by calculation
17
145
1.18
0.20
2.6
4.0
mmol/l
2.1
2.5
0.31
12
99
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
117
1.20
0.20
1.1
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
10
80
1.25
0.20
1.0
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
112
0.80
0.20
1.1
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
94
890
1.06
0.20
1.6
1.7
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
50
1.20
0.19
1.2
1.9
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
21
184
1.14
0.19
1.2
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
6
53
1.13
0.18
1.0
1.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
15
128
1.17
0.18
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
25
223
1.12
0.18
1.1
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
58
1.21
0.18
1.1
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
19
166
1.15
0.18
1.1
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
60
1.17
0.18
2.0
2.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
60
1.17
0.18
1.3
1.6
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
62
1.13
0.17
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
62
1.13
0.17
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
62
1.13
0.17
1.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
25
224
1.12
0.17
1.1
1.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
90
856
1.06
0.17
5.2
5.8
mmol/l
1.0
1.0
0.27
85
796
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
63
1.11
0.17
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
63
1.11
0.17
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
63
1.11
0.17
1.0
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
66
0.76
0.17
1.0
1.1
—
—
—
0
0
(4281824)
5
68
0.73
0.17
1.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
120
0.83
0.16
2.4
2.7
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
12
101
1.19
0.16
1.0
1.1
—
—
—
0
0
(4146454)
8
68
1.18
0.16
3.4
2.6
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
25
225
1.11
0.16
2.9
4.3
mmol/l
1.4
1.3
0.12
25
219
(3050129) First trimester maternal screen panel - Serum or Plasma
26
287
0.90
0.16
1.4
1.4
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
19
168
1.13
0.15
1.2
1.4
e6/l
3.3
10.7
0.95
14
127
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
78
0.77
0.15
1.0
1.9
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
9
78
1.16
0.15
1.4
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
23
255
0.90
0.15
2.2
3.6
u/ml
1020.8
5241.7
0.55
18
226
(3021879) Hepatitis B virus core Ab [Presence] in Serum
68
645
1.06
0.14
1.5
1.5
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
13
112
1.16
0.14
1.0
1.0
u/ml
0.2
0.7
—
7
27
(21494755) Public health laboratory ask at order entry panel
106
1019
1.05
0.14
1.4
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
25
227
1.10
0.14
1.1
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
84
1.19
0.14
1.0
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
27
247
1.10
0.13
1.4
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
27
247
1.10
0.13
1.4
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
28
257
1.09
0.13
1.1
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
20
180
1.11
0.13
3.7
3.8
ratio
1.0
1.3
—
5
22
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
11
94
1.17
0.13
1.2
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
27
248
1.09
0.13
1.4
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
27
248
1.09
0.13
1.4
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
58
551
1.06
0.12
3.0
2.4
ml/min/173m2
77.3
70.9
0.64
22
230
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
12
137
0.87
0.12
1.1
1.0
u/ml
0.9
2.0
—
6
61
(3001019) Free T4 and TSH panel - Serum or Plasma
47
496
0.94
0.11
1.4
1.6
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
14
124
1.13
0.11
1.0
1.1
u/ml
1.0
3.5
—
8
46
(3002032) Base excess in Venous blood by calculation
58
553
1.05
0.11
4.8
3.7
mmol/l
2.3
1.9
0.42
49
438
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
43
406
1.06
0.11
3.0
3.3
mmol/l
1.9
1.7
0.15
35
294
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
56
587
0.95
0.11
1.3
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
42
397
1.06
0.10
2.6
2.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
135
1.11
0.09
1.4
1.7
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
87
1.15
0.09
1.0
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
47
1.06
0.09
3.6
3.0
u/ml
509.2
1249.2
—
5
47
(40761536) Microorganisms panel - Urine sediment
66
635
1.04
0.09
3.2
3.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
48
1.04
0.09
1.2
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
21
194
1.08
0.09
2.2
3.0
u/ml
0.3
0.4
0.36
12
99
(3005033) Fetal Nuchal fold Thickness US
22
204
1.08
0.08
1.5
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
89
864
1.03
0.08
1.5
1.7
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
57
1.05
0.08
3.2
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
25
267
0.93
0.08
1.7
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
17
185
0.92
0.08
1.8
1.7
—
—
—
0
0
(3036489) Thrombin time
30
283
1.06
0.08
1.5
2.0
s
20.3
21.6
1.38
23
246
(21494890) Protein electrophoresis panel - 24 hour Urine
7
65
1.08
0.08
4.0
2.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
66
1.06
0.08
1.1
1.7
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
66
1.06
0.08
4.1
4.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
22
205
1.07
0.08
1.5
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
12
133
0.90
0.07
1.7
1.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
50
481
1.04
0.07
2.3
3.0
g/l
67.5
67.1
0.12
45
440
(3045414) Leukocytes [Presence] in Urine
29
306
0.95
0.07
2.4
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
9
84
1.07
0.07
2.7
2.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
17
157
1.08
0.07
1.3
1.5
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
23
216
1.07
0.07
2.7
2.0
pmol/l
225.3
210.7
0.33
23
206
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
94
0.85
0.06
1.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
11
99
1.11
0.06
1.5
1.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
67
651
1.03
0.06
1.8
2.2
g/l
0.2
0.2
0.25
59
620
(3009343) pH of Capillary blood
44
424
1.04
0.06
3.2
3.2
ph
7.4
7.4
—
5
53
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
37
355
1.04
0.06
2.0
1.8
mg/l
3.6
3.5
0.04
25
242
(3014051) Protein [Presence] in Urine by Test strip
15
139
1.08
0.05
3.3
1.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
120
1.08
0.05
1.2
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
28
268
1.05
0.04
1.6
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
22
209
1.05
0.04
1.5
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
22
210
1.05
0.03
1.6
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
17
179
0.95
0.03
1.4
1.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
25
259
0.96
0.02
1.8
2.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
15
158
0.95
0.02
1.2
1.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
23
238
0.97
0.02
1.0
1.2
—
904.0
—
0
5
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
10
93
1.08
0.02
1.0
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
197
1959
1.01
0.01
4.3
3.5
estimate
0.0
0.0
1.08
68
693
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
33
338
0.98
0.01
1.8
2.1
u/l
40.0
38.4
0.19
28
307
(4306422)
13
123
1.06
0.01
1.2
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
14
133
1.05
0.01
1.0
1.0
u/ml
0.5
2.7
—
8
47
(1616796) Gas panel - Central venous blood
15
143
1.05
0.01
2.5
3.1
—
—
—
0
0
(3002256) Pathology report gross observation
91
918
0.99
0.01
1.3
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
17
176
0.97
0.00
1.5
1.8
—
—
—
0
0
(4034850)
23
224
1.03
0.00
7.3
9.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
32
314
1.02
0.00
3.4
3.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
13
126
1.03
0.00
2.2
2.6
%
16.4
16.9
—
7
67
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
14
136
1.03
0.00
1.9
1.6
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
15
154
0.97
0.00
1.2
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
45
452
1.00
0.00
1.5
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
35
351
1.00
0.00
1.5
1.5
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
11
107
1.03
0.00
1.4
2.1
—
1600.0
—
0
5
(3024928) Oxygen saturation in Venous blood
14
137
1.02
0.00
4.4
2.9
—
—
—
0
0
(3010421) pH of Blood
17
167
1.02
0.00
2.6
4.0
ph
7.4
7.4
0.12
17
142
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
19
187
1.02
0.00
2.4
2.5
ug/min
49.0
93.0
—
10
113
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
14
139
1.01
0.00
1.1
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
85
847
1.00
0.00
4.6
4.2
%
31.1
31.4
0.08
61
575
(3004119) Hemoglobin [Mass/volume] in Venous blood
37
375
0.99
0.00
3.4
3.3
g/l
133.0
129.5
0.45
37
367
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
16
165
0.97
0.00
1.0
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
16
155
1.03
0.00
1.1
1.3
u/ml
185.9
270.1
—
10
94
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.1
—
15.2
—
0
8
(3001556) Androgen free Index in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.0
—
18.0
—
0
7
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
58
0.86
0.00
2.0
1.7
g/l
0.9
1.0
—
5
58
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
54
0.93
0.00
1.0
1.1
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
7
0.00
0.00
0.0
1.6
—
0.4
—
0
7
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
17.0
—
0
7
(3013762) Body weight Measured
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
2.6
—
0
5
(3003721) Smooth muscle Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
9
91
0.99
0.00
1.0
1.4
mu/l
195.6
45.2
—
9
83
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
3.7
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
85
0.94
0.00
1.3
2.3
pg
35.1
32.8
—
8
85
(3035637) Corticotropin [Mass/volume] in Plasma
7
74
0.95
0.00
1.6
1.6
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
12.1
—
0
6
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
79
1.01
0.00
1.0
1.2
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
7
73
0.96
0.00
1.0
1.0
mg/l
272.3
286.9
—
7
65
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
59
0.85
0.00
1.0
1.0
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
190.6
—
0
5
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
62
0.97
0.00
2.0
2.5
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
74
0.95
0.00
1.1
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
68
0.88
0.00
1.0
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
55
0.91
0.00
2.6
1.4
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
81
0.99
0.00
1.4
1.7
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
5
55
0.91
0.00
1.2
2.2
—
39.7
—
0
7
(3000285) Sodium [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
55
0.91
0.00
2.0
2.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
55
0.91
0.00
1.0
1.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
6
68
0.88
0.00
1.2
1.3
nmol/l
3.3
1.4
—
6
63
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_INJURY_MUSCLE_TENDON_ANKLE_FOOT_LEVEL – Injury of muscle and tendon at ankle and foot level

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).